GuidelineMMWR. Morbidity and mortality weekly report2013

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Centers for Disease Control and Prevention (CDC)PubMed ↗Full text ↗

No numbers read from the abstract.